SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001493152-21-011550
Filing Date
2021-05-14
Accepted
2021-05-14 17:20:01
Documents
24

Document Format Files

Seq Description Document Type Size
1 formdefm14a.htm DEFM14A 6366270
2 logo_001.jpg GRAPHIC 2512
3 image_001.jpg GRAPHIC 3235
4 forms-4_001.jpg GRAPHIC 19199
5 forms-4_002.jpg GRAPHIC 19870
6 forms-4_003.jpg GRAPHIC 20849
7 forms-4_004.jpg GRAPHIC 20795
8 forms-4_005.jpg GRAPHIC 25143
9 forms-4_006.jpg GRAPHIC 16125
10 forms-4_007.jpg GRAPHIC 21479
11 forms-4_008.jpg GRAPHIC 20895
12 forms-4_009.jpg GRAPHIC 28278
13 forms-4_010.jpg GRAPHIC 20752
14 forms-4_011.jpg GRAPHIC 20761
15 forms-4_012.jpg GRAPHIC 23459
16 forms-4_013.jpg GRAPHIC 23483
17 forms-4_014.jpg GRAPHIC 26296
18 forms-4_015.jpg GRAPHIC 40147
19 forms-4_016.jpg GRAPHIC 35159
20 forms-4_017.jpg GRAPHIC 78964
21 forms-4_018.jpg GRAPHIC 41915
22 forms-4_019.jpg GRAPHIC 51164
23 img_001.jpg GRAPHIC 2475
24 logo_002.jpg GRAPHIC 6988
  Complete submission text file 0001493152-21-011550.txt   7154843
Mailing Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512
Business Address 12 HARTOM STREET HAR HOTZVIM JERUSALEM L3 777512 97225864657
Intec Pharma Ltd. (Filer) CIK: 0001638381 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-37521 | Film No.: 21926079
SIC: 2834 Pharmaceutical Preparations